Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Stocktwits
stocktwits.com > news-articles > markets > equity > sarepta-hits-fresh-hurdle-as-court-revives-patent-lawsuit-with-regenxbio-over-muscular-disorder-therapy > cZRNSgQR4xu

Sarepta Hits Fresh Hurdle As Court Revives Patent Lawsuit With Regenxbio Over Muscular Disorder Therapy

10+ hour, 27+ min ago   (305+ words) The U.S. Court of Appeals for the Federal Circuit has reportedly reinstated the patent lawsuit between Regenxbio (RGNX) and Sarepta Therapeutics (SRPT) regarding the latter’s Duchenne muscular dystrophy (DMD) treatment. According to a Reuters report, the court reversed a Delaware federal…...

Kavout
kavout.com > market-lens > why-is-mbx-biosciences-new-cbo-appointment-so-significant-for-investors

Why is MBX Biosciences' new CBO appointment so significant for investors

5+ hour, 47+ min ago   (986+ words) Kavout | AI Why is MBX Biosciences' new CBO appointment so significant for investors - MBX Biosciences' recent appointment of Karen Basbaum as Chief Business Officer signals a strategic pivot towards high-value partnerships and potential M&A to de-risk and accelerate its…...

Punch Newspapers
punchng.com > drugmakers-finance-costs-jump-47-amid-high-interest-rates

Drugmakers’ finance costs jump 47% amid high interest rates

3+ hour, 20+ min ago   (951+ words) Nigerian pharmaceutical companies listed on the Nigerian Exchange recorded a 46.5 per cent increase in combined finance costs in the first quarter of 2026, as high interest rates and growing reliance on debt continued to squeeze profitability across the sector. For stock…...

BioPharma APAC
biopharmaapac.com > analysis > 92 > 8237 > 7-countries-competing-to-be-the-regions-next-biomanufacturing-hub.html

7 Countries Competing to Be the Region’s Next Biomanufacturing Hub

10+ hour, 27+ min ago   (1410+ words) 25 July 2026 | Saturday | Analysis One caveat before the table. This is not the APAC Bioeconomy Index, which is a separate benchmark with its own methodology and a different purpose. This is a siting-decision comparison written for people choosing where to put…...

Medical Dialogues
medicaldialogues.in > amp > news > industry > pharma > bain-capital-to-acquire-uks-top-vitamin-brand-vitabiotics-in-usd-900-million-deal-175770

Bain Capital to Acquire UK's Top Vitamin Brand Vitabiotics in USD 900 Million Deal

11+ hour, 46+ min ago   (309+ words) New Delhi: Bain Capital has agreed to acquire Vitabiotics, the UK's leading vitamin company, including its UK business and the wider VB Group, which includes Meyer Organics in India and operations in Africa. While the deal value was not officially…...

Macau Business
macaubusiness.com > nova-biomedical-advances-integrated-cell-line-development-workflows-nanocellect-products-are-now-part-of-nova-biomedical

Nova Biomedical Advances Integrated Cell Line Development Workflows: NanoCellect products are now part of Nova Biomedical

4+ hour, 10+ min ago   (119+ words) WALTHAM, Mass., July 24, 2026 /PRNewswire/ — Nova Biomedical today announced a transaction involving certain assets of NanoCellect, a provider of microfluidic cell sorting technology. This expansion of Nova’s portfolio will accelerate cell line development timelines and improve clone selection outcomes, while establishing…...

Blaze Media
theblaze.com > tech > brainless-humans-backup-bodies-inside-biotech-s-depraved-new-world

Brainless humans? Backup bodies? Inside biotech's depraved new world

10+ hour, 46+ min ago   (630+ words) Rumors fly amid new tech that would make Frankenstein blush. Social media's magicians spent decades perfecting the art of slicing human attention into advertising revenue. Is the next step on the corporate road map farming human tissue for spare parts?...

Business Plus
businessplus.ie > interviews > startup-thrives-pressure-nazata-bio

Nazata Bio: The Startup That Thrives on Pressure

13+ hour, 16+ min ago   (1634+ words) Nazata Bio co-founder Tom McCartan was seeking a chief technology officer when he called former classmate Shane O’Neill to seek recommendations. At the time, O’Neill was preparing to return to Ireland from Japan, where he had worked in software for…...

The Pharma Letter
thepharmaletter.com > pharma-news > india-s--pharma-m-and-a-market-hits-four-year-high-on-blockbuster-deals

India’s pharma M&A market hits four-year high on blockbuster deals

12+ hour, 50+ min ago   (248+ words) The Pharma Letter - India’s pharma M&A market hits four-year high on blockbuster deals India’s mergers and acquisitions (M&A) market hit a four-year high in the April to June quarter, powered by a single blockbuster: Sun Pharmaceutical Industries' (BOM:…...

Google News
finance.biggo.com > news > 432bb892fdad93ad

Amilabs CEO LeBrun: The Real Cost of a $1.2 Billion Seed Round Is Expectations, Not Dilution — BigGo Finance

19+ hour, 7+ min ago   (412+ words) This is not a subtle academic distinction. It defines which technology can actually power a robot that operates safely in your kitchen. The current industry attempt to stuff LLMs into robotics — Vision-Language-Action models — is, in LeBrun’s blunt assessment, a temporary…...